Quick Answer
bioAffinity Technologies, Inc. reported Gross Profit of $4.3 thousand for the year ending 2022.
- This data is from bioAffinity Technologies, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2023.
- XBRL data for this metric is available from 2022 to 2022 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $1.2 thousand | Q3 2022: $1.0 thousand | Q1 2023: $834.00 | Q2 2023: $18.5 thousand | Q3 2023: $223.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: